ArticleJSES international2026
Longitudinal evaluation of patient-reported outcome measures and clinician-based scores after reverse shoulder arthroplasty in Asian patients: patient-reported outcome measures may be sufficient beyond 1 year.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reverse total shoulder arthroplasty (rTSA) provides reliable outcomes for irreparable cuff tears and arthropathy, although most data are Western populations. Asian patients have smaller physiques, lower bone density, and greater internal rotation requirements, which may affect outcomes. Clinician-based scores (eg, Japanese Orthopedic Association [JOA] score) remain standard; however, patient-reported outcome measures (PROMs), including the American Shoulder and Elbow Surgeons (ASES) score, are increasingly adopted worldwide. Whether PROMs reflect recovery or replace clinician evaluations in Asian patients remains unclear. Accordingly, we aimed to compare PROMs and clinician-based scoring systems in Asian patients undergoing rTSA, spanning from the preoperative phase to 2 years post-operatively, and to evaluate longitudinal correlations between these measures. Methods: This retrospective study included 211 rTSA-treated shoulders (July 2016-March 2022). Evaluations were conducted pre-operatively and at 3, 6, 12, and 24 months using JOA, University of California, Los Angeles (UCLA), and Constant-Murley (CS) scores. The ASES score served as the PROM. Longitudinal changes were analyzed using the Friedman test and Bonferroni correction. To assess ASES utility at 2 years, receiver operating characteristic and linear regression analyses evaluated its correlation with clinician scores and prediction of favorable outcomes (JOA ≥ 83, CS ≥ 57, UCLA ≥ 28). Results: Forward flexion, abduction, and all scores (ASES, JOA, UCLA, CS) improved significantly by 1 year ( Conclusions: Most recovery after rTSA occurs within 1 year and then stabilizes. PROMs like ASES reliably assess long-term rTSA outcomes, as demonstrated in this Japanese cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.